<DOC>
	<DOCNO>NCT02412852</DOCNO>
	<brief_summary>In study , subject diabetic neuropathic pain ( DNP ) treat 12 week either placebo , 40 80 mg sustain release sodium nitrite ( TV1001sr ) twice daily . Primary endpoint safety pharmacokinetics . Assessment study medication affect pain follow treatment also record .</brief_summary>
	<brief_title>A Phase 2a Study Assess Safety &amp; Pharmacokinetics Sustained Release Sodium Nitrite Patients With Diabetic Pain</brief_title>
	<detailed_description>This dose-ranging study evaluate safety , pharmacokinetics , tolerability multiple dose oral , sustained release formulation sodium nitrite ( TV1001sr ) subject DNP . The primary objective ass safety tolerability multiple dos twice daily 40 mg 80 mg TV1001sr compare placebo 12 week treatment period pharmacokinetics sustain release formulation sodium nitrite . Secondary objective evaluate pharmacokinetics marker functional improvement include pain questionnaire , quantitative sensory test change marker diabetes .</detailed_description>
	<criteria>Female subject must postmenopausal , sterilize use suitable birth control Diagnosis diabetes ( HbA1c &gt; 6.0 ) Diagnosis diabetic peripheral neuropathy pain foot Presence ongoing diabetic neuropathic least 3 month A pain score great equal 4 Numerical Pain Rating Scale screen Ability provide write informed consent Patients fibromyalgia regional pain cause lumbar cervical compression History diagnosis significant neurological disease History diagnosis clinically significant psychiatric disease Serious liver disease Poorly control diabetes Hypersensitivity sodium nitrite related compound Life expectancy &lt; 6 month A chronic illness may increase risk associate study Active malignancy require active antineoplastic therapy , opinion investigator , interfere study treatment participation Pregnant nursing woman Current diagnosis alcohol substance abuse Current use sildenafil phosphodiesterase Type 5 Inhibitors History methemoglobinemia , ( metHb â‰¥ 15 % ) Subject involve litigation receive worker 's compensation Inability speak English</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>neuropathy</keyword>
</DOC>